Swiss Biotech NBE Therapetics procures $22 mln Series C
NBE-Therapeutics AG, a Swiss biotech firm, has raised $22 million in Series C financing.
NBE-Therapeutics AG, a Swiss biotech firm, has raised $22 million in Series C financing.
Copyright PEI Media
Not for publication, email or dissemination